admin

Discontinuation of the test option microdeletion 22q11.2 (DiGeorge syndrome) 28. March 2022 We have been analyzing the 22q11.2 microdeletion 22q11.2 (DiGeorge syndrome) as part of the Harmony® Test since July 2018. We now evaluated the data from more than 50000 cases. The evaluation of the data shows that of the cases tested positive for DiGeorge syndrome […]

Analysis of the Harmony Test from April 1st, 2022 exclusively in Tübingen, Germany 25. March 2022 We are pleased to inform you that due to the expansion of our laboratory space, all incoming samples will be processed in our Lab in Tübingen from April 1st, 2022. Analysis of the Harmony Test from April 1st, 2022 exclusively in

Determination of the fetal RhD status from maternal blood 14. September 2021 In Europe around 17% of all pregnant women are RhD-negative. Since the beginning of the 1990s, these women have been receiving RhD prophylaxis in the 28th to 30th week of pregnancy in addition to the targeted postpartum administration. This prenatal Rh prophylaxis, which